Compare BAK & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BAK | BHVN |
|---|---|---|
| Founded | 1972 | 2013 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | N/A | 2017 |
| Metric | BAK | BHVN |
|---|---|---|
| Price | $2.93 | $11.10 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 15 |
| Target Price | $4.40 | ★ $29.79 |
| AVG Volume (30 Days) | 784.0K | ★ 2.8M |
| Earning Date | 11-11-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $13,841,708,237.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.81 | $1,147.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.32 | $7.48 |
| 52 Week High | $5.10 | $44.28 |
| Indicator | BAK | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 51.52 | 53.32 |
| Support Level | $2.78 | $8.50 |
| Resistance Level | $3.13 | $11.80 |
| Average True Range (ATR) | 0.12 | 0.91 |
| MACD | -0.00 | 0.08 |
| Stochastic Oscillator | 51.09 | 81.83 |
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.